Initially established in 1971, Beijing Beiwei Pharmaceuticals Co., Ltd. (BBP) is a joint stock company regrouped on the basis of Beijing Beiwei Pharmaceutical Factory, which is invested by Beijing Medical School, Beijing Wanbo Technological Development Co., Ltd. and Beijing Xiyue Health Products Co., Ltd.

BBP’s business scope covers from traditional Chinese medicines, western medicines, troches (including Cephalosporins), granules (including Cephalosporins), capsules (including Cephalosporins), soft capsules, pills, pulvis, powders, syrups, mixtures, and oral liquids to tinctures. We have both full range of products and the license to export and import. A wide variety of products have gained quality awards home and abroad, such as “Qi Rong Run Chang” oral liquid is state-level new drug in 2000. BBP’s yearly productive capacity is 1 billion tablets, 60 million packages of Granules, 100 million capsules, 100 million soft capsules, 60 million packages of pulvis, 30 million oral liquids and the Chinese herb plant could decoct 2 tons traditional Chinese herb. All the dosage forms have been passed national GMP audit.

BBP’s strong technical team consists of technical consultant Professor Jin Shiyuan from China Association of Chinese Medicine, QA manager Mr. Cao Zhaobo from Beijing Tongrentang pharmaceutical factory etc. Licensed pharmacists and technicians upon pharmacist post title account for 26% of all. Employees from management staffs to technicians who have been occupied with pharmaceuticals for 30 years are pharmaceutical engineers and undergraduates with major in pharmacy. All the major person-in-charge of production and technology are technical backbone of Beijing Double Crane High-Tech Natural Pharmaceuticals.

With the enterprise concept of “innovation and excellence oriented, for the benefit of the people”, we take “pursuit of superexcellence and quality, safe, reliable, and effective remedy supplies, improvement of employees’ living standards” as enterprise values. Enterprise management is in total accordance with GMP standards and production process is completed under powerful supervision executed by thousands of management software. There are also 3 levels of QA and QC teams in BBP.

The development target for BBP is to develop itself into an enterprise with integration of science, industry and trade. BBP has drawn up agreements on joint development of new remedies with research institutes such as National Drugs R&D Center, the College of Pharmacy at Beijing University etc., which has laid firm basis for the development of BBP. With the spirit of “innovation and excellence oriented, for the benefit of the people”, BBP is moving forward to be wholeheartedly at your service. Not only has BBP donated money and drugs in battle against SARS in 2003, but BBP coordinated with Drug Administration Department to assure preventive drug supplies. Even though their personal interests are sacrificed, they have made contribution for the victory of “fighting against SARS”. In the days and weeks following “May 12 Wenchuan earthquake” in 2008, BBP was the first to donate much needed remedies to the relevant department, employees also contributed and sent their private donations to the civil affairs department at the top speed.

For the time being, BBP has entered a new historical stage. The feature and promise of BBP is to constantly pursue superexcellence and high quality, supply safe, reliable and effective remedy to the patients. Each of the clients, friends and copartners will be deeply honored in BBP, the firm basis for maintaining BBP’s core competiveness in the market comes from the establishment of long-term and mutually beneficial cooperative relationship with global distributors.

With more than 30 years practice, we review the past in the light of present and sigh with all sorts of feeling. While we look forward to the future, there is also a long way for us to go. BBP’s whole
leadership team will work together with practical and innovative spirit to accomplish resource integration and structural adjustment. We’ll be vigorous to conquer the difficulties and try our best to do solid and the second pioneering job, which will help achieve BBP’s new refulgence, devoting greater power to the development of China’s national medicine.